MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,682,357 | -75.6% | 46,564 | -74.9% | 0.01% | -94.2% |
Q1 2023 | $6,888,710 | +261.1% | 185,280 | +340.1% | 0.10% | +197.1% |
Q4 2022 | $1,907,460 | +763.1% | 42,098 | +1464.4% | 0.04% | +483.3% |
Q1 2022 | $221,000 | -92.9% | 2,691 | -87.2% | 0.01% | -93.8% |
Q4 2021 | $3,095,000 | +438.3% | 21,096 | +372.8% | 0.10% | +159.5% |
Q4 2019 | $575,000 | -19.2% | 4,462 | -35.5% | 0.04% | -52.6% |
Q2 2019 | $712,000 | -35.3% | 6,920 | -53.9% | 0.08% | -56.9% |
Q1 2019 | $1,100,000 | – | 15,000 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |